Glaxosmithkline | Marketskapitalisme



Market Capitalization Endring Dato
AbbVie USD 306.72B 7.3B 2025-04
Amgen USD 155.38B 15.41B 2025-04
AstraZeneca GBP 157.7B 4.61B 2025-04
Aurora Cannabis CAD 334.54M 11.06M 2025-04
Bristol-Myers Squibb USD 100.66B 14.06B 2025-04
Canopy Growth CAD 612.33M 169.68M 2024-12
Corcept Therapeutics USD 7.26B 1.98B 2025-04
Eli Lilly USD 706.59B 26.28B 2025-04
GlaxoSmithKline GBP 55.34B 469.7M 2025-04
Glaxosmithkline USD 73.89B 4.07B 2025-04
Indivior 1.28B 375.31M 2025-04
J&J USD 371.76B 27.89B 2025-04
Merck USD 196.74B 54.91B 2025-04
Novartis CHF 194.25B 18.5B 2024-12
Pacira USD 1.15B 277M 2025-04
Perrigo USD 3.51B 70M 2024-12
Pfizer USD 126.33B 24.01B 2025-04
Prestige Brands USD 4.02B 157M 2025-04
Sanofi EUR 118.41B 10.58B 2024-12
Supernus Pharmaceuticals USD 1.7B 316M 2025-04
Takeda JPY 6.61T 2.95B 2025-04
Teva Pharmaceutical Industries ILS 91.91B 16.81B 2024-12
Zoetis USD 68.18B 5.26B 2025-04



Glaxosmithkline Marketskapitalisme - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.